Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Crohn Disease 1Colorectal Neoplasms 1

Interventions

Infliximab 5Certolizumab Pegol 5Adalimumab 3Nivolumab 2MEDI2070 2Educational Status 2CT-P13 2vedolizumab 1secukinumab 1golimumab 1cabozantinib 1Vitamin E 1Vaccines 1Ustekinumab 1Sutures 1Surveys and Questionnaires 1Surgical Instruments 1Standard of Care 1Specimen Handling 1Soybean Oil 1Saline Solution 1Ringer's Lactate 1Proctocolectomy, Restorative 1Practice Guidelines as Topic 1Pneumococcal Vaccines 1Platinum Compounds 1Photoplethysmography 1Phlebotomy 1Papillomavirus Vaccines 1Methoxsalen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Crohn Disease × Photoplethysmography × Clear all
NCT02343601 2026-04-02

PANEX3

University Hospital, Caen

Phase 3 Completed
160 enrolled
Gastrointestinal

Crohn Disease, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡